KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 153 filers reported holding KRYSTAL BIOTECH INC in Q3 2022. The put-call ratio across all filers is 3.48 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $591,136 | -7.3% | 5,096 | -6.2% | 0.01% | 0.0% |
| Q2 2023 | $637,717 | +52.5% | 5,432 | +4.0% | 0.01% | +25.0% |
| Q1 2023 | $418,073 | +4.1% | 5,222 | +3.0% | 0.00% | 0.0% |
| Q4 2022 | $401,566 | +18.1% | 5,069 | +4.0% | 0.00% | 0.0% |
| Q3 2022 | $340,000 | +9.7% | 4,876 | +3.3% | 0.00% | +33.3% |
| Q2 2022 | $310,000 | -1.3% | 4,718 | +0.1% | 0.00% | 0.0% |
| Q1 2022 | $314,000 | +15.4% | 4,712 | +21.3% | 0.00% | +50.0% |
| Q4 2021 | $272,000 | +32.7% | 3,885 | -1.2% | 0.00% | 0.0% |
| Q3 2021 | $205,000 | -22.1% | 3,931 | +1.5% | 0.00% | 0.0% |
| Q2 2021 | $263,000 | -8.4% | 3,873 | +3.9% | 0.00% | -33.3% |
| Q1 2021 | $287,000 | +29.3% | 3,729 | +0.6% | 0.00% | +50.0% |
| Q4 2020 | $222,000 | – | 3,706 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,913,280 | $153,177,197 | 6.65% |
| Frazier Life Sciences Management, L.P. | 945,407 | $75,689,284 | 5.48% |
| S Squared Technology, LLC | 108,215 | $8,663,693 | 5.14% |
| Nicholas Investment Partners, LP | 374,718 | $29,999,923 | 2.28% |
| Avoro Capital Advisors LLC | 1,750,000 | $140,105,000 | 2.08% |
| Artal Group S.A. | 412,082 | $32,991 | 1.96% |
| First Light Asset Management, LLC | 195,980 | $15,690,159 | 1.41% |
| Integral Health Asset Management, LLC | 85,000 | $6,805,100 | 1.37% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $4,883,660 | 1.36% |
| Hood River Capital Management LLC | 447,393 | $35,818,000 | 1.16% |